drugset / Trial / NCT00619034

Pharmacological Intervention in Diabetic Retinopathy

NCT00619034

Completed 87 enrolled University of Aarhus
RandomizedCrossoverSingle-blindPrevention

Summary

The purpose of this study is to determine if diabetic retinopathy can be treated with prostaglandin analogues, prostaglandin synthesis inhibitors or carbonic anhydrases inhibitors.

Timeline

Start
2007-09
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diclofenac Other / unclassified Other
Subject Dorzolamide Small molecule Other
Subject Latanoprost Small molecule Other

Indications